| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.00031 | 1 |